MedPath

PMS-CLONAZEPAM

PMS-CLONAZEPAM

Approved
DIN Number

02048701

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

Pharmascience Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02048701
AIG Number0111558001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N03AE01 CLONAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

CLONAZEPAMActive
Strength: 0.5 MG
Monograph: CLONAZEPAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.